CE-IVD Oncology Applications by SOPHiA GENETICS™

Supporting fast and reliable precision diagnostics with CE-IVD applications powered by SOPHiA DDM™

Discover our CE-IVD Oncology Solutions

We are here to simplify your transition to the new regulatory environment. You can leverage our CE-in vitro diagnostic (IVD) labeled platform and CE-IVD Oncology Applications while staying compliant with IVDD during this transition period. See in our Frequently Asked Questions section for more answers.​

Get ready for a streamlined workflow –
From sample to data to insight​

Our CE-IVD Oncology Applications provide you with robust, meaningful clinical results and help you to discover the full power of your data for your patients. Leverage the potential of an end-to-end CE-IVD solution in oncology genetic testing and reporting.​

Accurate and reliable testing

Confident detection of actionable variants

Reduced time to patient benefit

EU IVD directive compliant solutions and software

Contact us to know more

pink dots icon

Discover our CE-IVD Oncology Applications

SOPHiA DDM™ Dx Homologous Recombination Deficiency (HRD) Solution​

Support accurate detection of HRD status in ovarian cancer patients by leveraging low-pass WGS to measure genomic scarring.​

SOPHiA DDM™ For Solid Tumors

SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS)​

Expect more from your RNA analyses with reliable partner-agnostic detection of fusions in small lung cancer biopsy samples.​

SOPHiA DDM™ For Solid Tumors

SOPHiA DDM™ Dx Solid Tumor Solution (STS)​

Benefit from advanced molecular profiling of solid tumors, including lung, colorectal, skin and brain, with confident SNV and Indel detection in relevant genes.​

SOPHiA DDM™ For Solid Tumors

SOPHiA DDM™ Dx Myeloid Solution​ (MYS)

Expand the scope of myeloid neoplasms management with advanced analytical performance for the detection of pertinent SNVs, Indels and FLT3-ITDs.

SOPHiA DDM™ For Solid Tumors

SOPHiA DDM™ Dx Hereditary Cancer Solution (HCS)

Confidently assess crucial variants associated with hereditary cancers with tailored analytics that accurately detect key SNVs and Indels.

SOPHiA DDM™ For Solid Tumors

Indels, insertions/deletions. ITDs, internal tandem duplications; SNVs, single nucleotide variants; WGS, whole genome sequencing

';